Paid Clinical Trials in Long Beach, CA
As of July 2026, 196 paid clinical trials are recruiting in Long Beach, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Long Beach offers studies at sites including Miller Children's and Women's Hospital Long Beach for conditions such as ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Myeloid Leukemia, Acute Respiratory Distress Syndrome. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Long Beach
Trials by drug in Long Beach
Filter results
Newly added in Long Beach
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
183 clinical trials
↓ Download CSVA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 2 Study to Assess the Safety and Efficacy of ANG003
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Top Research Study Locations in Long Beach
Researchers run research studies in Long Beach, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Miller Children's and Women's Hospital Long Beach | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Malignant Solid Neoplasm | 22 |
| VA Long Beach Healthcare System, Long Beach, CA | Alcohol Use Disorder, Atherosclerosis, Carcinoma, Hepatocellular | 17 |
| Ark Clinical Research | Obesity, Overweight, Diabetes Mellitus, Type 2 | 16 |
| City of Hope at Long Beach Elm | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Advanced Colon Adenocarcinoma | 14 |
| Long Beach Memorial Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 10 |
| Tibor Rubin VA Medical Center | Stage IVB Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 7 |
| Alliance for Research Alliance for Wellness | Migraine, Episodic Migraine, Migraine Prophylaxis | 6 |
| Healthy Brain Clinic | Alzheimers Disease, Alzheimer Disease, Alzheimer's Disease | 5 |
| Long Beach Research Institute | Diabetic Peripheral Neuropathic Pain, COVID-19 SARS-CoV-2 Infection, Diabetes Mellitus, Type 2 | 5 |
| Memorial Care Long Beach Medical Center | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 4 |
| Long Beach Clinical Trials | Atherosclerotic Cardiovascular Disease, COVID-19 SARS-CoV-2 Infection, Dermatitis Atopic | 4 |
| Adult & Child Neurology Medical Associates | Acute Treatment of Migraine, Migraine, Pediatric Migraine | 3 |
| Ark Clinical Research - Long Beach | Cortisol Excess, Metabolic Dysfunction-Associated SteatoHepatitis (MASH), Type 2 Diabetes | 3 |
| MemorialCare Long Beach Medical Center | AMI, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | 3 |
| Accellacare - Long Beach | Chronic Migraine, Major Depressive Disorder, Bipolar I Disorder | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| City of Hope | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 2 |
| GSK Investigational Site | HIV Infections, Systemic Lupus Erythematosus | 2 |
| Helios Clinical Research | Breast Cancer, Carcinoma, Non-Small-Cell Lung | 2 |
| Local Institution - 2607 | Alzheimer Disease, Agitation | 2 |
| Memorialcare Miller Children's & Women's Hospital Long Beach | Acute Treatment of Migraine, Focal Epilepsy | 2 |
| Neurocrine Clinical Site | Tardive Dyskinesia, Bipolar Disorder, Major Depressive Disorder | 2 |
| South Coast Retina Center | Age-related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 2 |
| VA Long Beach Healthcare System | Aortoiliac Occlusive Disease, Bladder Cancer, Peripheral Arterial Disease | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
Active & Upcoming Studies in Long Beach (2026)
Recruiting trials in Long Beach grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (54 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial · Phase 2 · City of Hope Medical Center
Neurology & pain (20 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Diabetes & metabolic (18 active studies)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes · Phase 2 · Novo Nordisk A/S
Cardiovascular (7 active studies)
- Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD · VA Office of Research and Development
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (5 active studies)
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder · Phase 2 · AbbVie
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor · Phase 4 · Neurocrine Biosciences
Eye & vision (4 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Pediatric (3 active studies)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
- Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset · The University of Texas Health Science Center, Houston
Vaccines (2 active studies)
- A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) · Phase 1, Phase 2 · AstraZeneca
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
HIV / STI (2 active studies)
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection · Phase 1 · GigaGen, Inc.
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics · Phase 1, Phase 2 · ViiV Healthcare
Common conditions studied in Long Beach
- ARDS (4 active studies)
- ARDS (Acute Respiratory Distress Syndrome) (4 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Acute Respiratory Distress Syndrome (4 active studies)
- Acute Respiratory Distress Syndrome (ARDS) (4 active studies)
- Asthma (4 active studies)
Leading research sponsors in Long Beach
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- AbbVie
- City of Hope Medical Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Long Beach?
There are approximately 196 recruiting clinical trials in Long Beach, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Long Beach pay participants?
Most recruiting trials in Long Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Long Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Long Beach?
The most common conditions under active study in Long Beach include ARDS (4), ARDS (Acute Respiratory Distress Syndrome) (4), Acute Myeloid Leukemia (4), Acute Respiratory Distress Syndrome (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Long Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Long Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Long Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Long Beach?
Recruiting research sites in Long Beach include Miller Children's and Women's Hospital Long Beach, VA Long Beach Healthcare System, Long Beach, CA, Ark Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Long Beach right now?
The largest active categories in Long Beach are Cancer & tumors (54), Neurology & pain (20), Diabetes & metabolic (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.